Literature DB >> 16816391

A systematic review of prion therapeutics in experimental models.

Clare R Trevitt1, John Collinge.   

Abstract

Prion diseases are transmissible, invariably fatal, neurodegenerative diseases which include Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy and scrapie in animals. A large number of putative treatments have been studied in experimental models over the past 30 years, with at best modest disease-modifying effects. The arrival of variant CJD in the UK in the 1990s has intensified the search for effective therapeutic agents, using an increasing number of animal, cellular and in vitro models with some recent promising proof of principle studies. Here, for the first time, we present a comprehensive systematic, rather than selective, review of published data on experimental approaches to prion therapeutics to provide a scientific resource for informing future therapeutics research, both in laboratory models and in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816391     DOI: 10.1093/brain/awl150

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  100 in total

Review 1.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

2.  Plasminogen: A cellular protein cofactor for PrPSc propagation.

Authors:  Charles E Mays; Chongsuk Ryou
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

Review 3.  Prions.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion.

Authors:  Chongsuk Ryou; William B Titlow; Charles E Mays; Younsoo Bae; Sehun Kim
Journal:  Biomaterials       Date:  2011-02-01       Impact factor: 12.479

5.  High-b-value diffusion MR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease.

Authors:  H Hyare; J Thornton; J Stevens; S Mead; P Rudge; J Collinge; T A Yousry; H R Jäger
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-10       Impact factor: 3.825

6.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Chemical induction of misfolded prion protein conformers in cell culture.

Authors:  Sina Ghaemmaghami; Julie Ullman; Misol Ahn; Susan St Martin; Stanley B Prusiner
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

9.  The most problematic symptoms of prion disease - an analysis of carer experiences.

Authors:  Liz Ford; Peter Rudge; Kathy Robinson; John Collinge; Michele Gorham; Simon Mead
Journal:  Int Psychogeriatr       Date:  2019-08       Impact factor: 3.878

Review 10.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.